International Stem Cell (OTCMKTS:ISCO) Stock Price Crosses Above 200 Day Moving Average – Time to Sell?

International Stem Cell Corp. (OTCMKTS:ISCO) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $0.16 and traded as high as $0.1654. International Stem Cell shares last traded at $0.1654, with a volume of 1,960 shares trading hands.

International Stem Cell Price Performance

The stock has a market cap of $1.32 million, a P/E ratio of -2.76 and a beta of -0.01. The company has a fifty day moving average of $0.17 and a 200 day moving average of $0.16.

International Stem Cell (OTCMKTS:ISCO) last issued its quarterly earnings results on Thursday, May 14th. The biotechnology company reported ($0.03) earnings per share (EPS) for the quarter. The business had revenue of $2.32 million during the quarter.

International Stem Cell Company Profile

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.